Breast cancer patients' narrative experiences about communication during the oncology care process: a qualitative study

Eur J Cancer Care (Engl). 2016 Sep;25(5):719-33. doi: 10.1111/ecc.12384. Epub 2015 Sep 28.

Abstract

To analyse the perception about the information and communication received to evaluate oncologic care of breast cancer patients in Spain. Qualitative study based on conducting in-depth interviews. An inductive thematic analysis of the illness narratives was performed. Intentional theoretical sampling of 41 people diagnosed with breast cancer. The information provided during care process is assessed as appropriate, as it includes personalised skills focused on communication and considers organisational and contextual issues. In some cases, the information was considered partial, heterogeneous and at times contradictory, which revealed a lack of continuity. To provide and adequately cover information needs from the patient perspective, it is necessary to ensure access, both in its physical (material) and intellectual (comprehension) dimension, keeping in mind elements of social capital (social networks) and cultural capital (values, beliefs, non-verbal language) that facilitate or hinder access. The current state of transition to a horizontal model in the doctor-patient relationship, could account for the difficulties, deficits and contradictions in communication and information that breast cancer patients perceive in many contexts.

Keywords: breast cancer; communication; information; patient-centred care; patients’ experiences; qualitative research.

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Agents / therapeutic use
  • Breast Neoplasms / psychology*
  • Breast Neoplasms / therapy
  • Breast Neoplasms, Male / psychology
  • Breast Neoplasms, Male / therapy
  • Communication*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Narration
  • Patient Education as Topic / standards
  • Patient Participation
  • Patient Satisfaction
  • Physician-Patient Relations
  • Qualitative Research
  • Social Support

Substances

  • Antineoplastic Agents